A Phase I Clinical Trial of FOLFIRI in Combination With the Pan-Cyclin-Dependent Kinase (CDK) Inhibitor Flavopiridol

Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-010-1269-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Cyclin-Dependent Kinase Inhibitor Flavopiridol (Alvocidib) Inhibits Metastasis of Human Osteosarcoma Cells

Oncotarget
Oncology
2018English

A Phase I Study of Cyclin-Dependent Kinase Inhibitor, AT7519, in Patients With Advanced Cancer: NCIC Clinical Trials Group IND 177

British Journal of Cancer
Cancer ResearchOncology
2014English

Risk Factors for Tumor Lysis Syndrome in Patients With Chronic Lymphocytic Leukemia Treated With the Cyclin-Dependent Kinase Inhibitor, Flavopiridol

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

A Phase I Trial of Flavopiridol in Relapsed Multiple Myeloma

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2013English

Phase I Trial of FOLFIRI in Combination With Sorafenib and Bevacizumab in Patients With Advanced Gastrointestinal Malignancies.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

The Effect of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on Anaplastic Large Cell Lymphoma Cells and Relationship With NPM-ALK Kinase Expression and Activity

Haematologica
Hematology
2009English

Preliminary Crysallization of a Cyclin-Dependent Kinase Inhibitor: P18

Acta Crystallographica Section A Foundations of Crystallography
1996English

Cdc14 Phosphatases Preferentially Dephosphorylate a Subset of Cyclin-Dependent Kinase (Cdk) Sites Containing Phosphoserine

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

The Cyclin-Dependent Kinase Inhibitor P27Kip1 Induces N-Terminal Proteolytic Cleavage of Cyclin A

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy